MorphoSys

is a Germany-based biopharmaceutical company that researches and develops oncology medicines for the treatment of cancer...
Read more
MorphoSys CEO: Arkadius Pichota

CEO

Arkadius Pichota

CEO Approval Rating

82/100

Est. Annual Revenue
$100-500M
Agree?
Est. Employees
250-500
Agree?
Funding
$841.6M
Acquisitions
2
Investments
1

MorphoSys Competitors

1BERLIN-CHEMIE AG
23B-Pharma
3iOmx
4STADA
5Biocept
6Carisma
7Numab
8Cardiff Oncology
9EnGeneIC
10NexImmune

Trending Companies